At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 23 enrolled
Drug / intervention
AN2728 Topical Ointment, 2%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of AN2728 Ointment in Adolescents With Atopic Dermatitis
In Brief
A Phase 2 clinical trial evaluating AN2728 Topical Ointment, 2% for Dermatitis, Atopic. Completed, enrolled 23 participants across 6 sites.
Detailed Summary
The purpose of this study is to investigate the safety, tolerability, and systemic exposure of AN2728 Topical Ointment, 2%, in subjects with atopic dermatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatitis, Atopic
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
First PostedJul 2012
Primary CompletionOct 2012
Study CompletionNov 2012
TodayJul 2026
First PostedJul 30, 2012
Enrollment StartJul 1, 2012
Primary CompletionOct 1, 2012
Study CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.9 years ago
Interventions
AN2728 Topical Ointment, 2%drug
AN2728 Topical Ointment, 2%